Evidence map›Paper›PMID 38841616›Full record

ReviewThe EPMA journal2024

Wenqian Xu, Tianchuang Yang, Jinyuan Zhang, Heguo Li, Min Guo

Abstract readReview
In one paragraph

Review in The EPMA journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Herbacetin as a novel therapeutic agent for pulmonary and renal fibrosis by targeting TGFBR2 for degradation.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  2. Nanoencapsulation ofRSC advances · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wenqian XuHenan University of Traditional Chinese Medicine, Zhengzhou, China.
Tianchuang YangZhongshan Huangpu People's Hospital, Zhongshan, China.
Jinyuan ZhangThe Third People's Hospital of Henan Province, Zhengzhou, China.
Heguo LiDepartment of Spleen, Stomach, Liver and Gallbladder, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China.ORCID 0000-0002-5289-868X
Min GuoDepartment of Spleen, Stomach, Liver and Gallbladder, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China.ORCID 0000-0003-1299-2927

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A natural "medicine and food" plant,

Indexed as

AdaptogensNeocoronitisNon-communicable illnessesPredictive preventive personalised medicine (PPPM / 3PM)Rhodiola roseaSuboptimal health

Identifiers

PMID38841616
PMCPMC11147995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.